| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/03/2000 | CA2357735A1 Modulation of immune response by ribavirin |
| 08/03/2000 | CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors |
| 08/03/2000 | CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 08/03/2000 | CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors |
| 08/03/2000 | CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 08/03/2000 | CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
| 08/02/2000 | EP1024199A2 Recovery of gamma-linolenic acid from protozoa of the genus Colpidium |
| 08/02/2000 | EP1024134A1 Aminobutanoic acid derivatives |
| 08/02/2000 | EP1023902A1 Pharmaceutical preparation for the treatment of inflammatory processes |
| 08/02/2000 | EP1023445A1 Cadherin derived growth factor and the application thereof |
| 08/02/2000 | EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 08/02/2000 | EP1023268A1 Isoquinolines as urokinase inhibitors |
| 08/02/2000 | EP1023263A1 Novel vitamin d analogues |
| 08/02/2000 | EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 08/02/2000 | EP1023073A1 Vitronectin receptor antagonist |
| 08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
| 08/02/2000 | EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES |
| 08/02/2000 | EP0729325A4 Osteogenic product and process |
| 08/02/2000 | EP0613373B1 Risedronate delayed-release compositions |
| 08/02/2000 | CN1261895A Cyclic azapeptide with angiogenic effect |
| 08/02/2000 | CN1261892A Diphosphonic acid salts for treatment of osteoporsis |
| 08/02/2000 | CN1261885A 2-substituted 4,5-diaryl imidazoles |
| 08/02/2000 | CN1261878A New cysteine derivatives processes for their production, and pharmaceuticals containing them |
| 08/02/2000 | CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 08/02/2000 | CN1261540A Medicine for curing aseptic necrosis of head of femur and preparing method |
| 08/02/2000 | CN1261534A Medicinal composition containing naphthyl compound |
| 08/02/2000 | CN1055019C Chinese herbal medicine powder for pharmacotherapeutic shoulder shield |
| 08/02/2000 | CN1054989C Biological resetting and setting fracture powder |
| 08/01/2000 | US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 08/01/2000 | US6096781 2-phenyl-1-benzothiophene derivatives are useful for treatment of osteoporosis and hyperlipemia |
| 08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
| 08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
| 08/01/2000 | US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases |
| 08/01/2000 | US6096739 Treatment for CNS injuries |
| 08/01/2000 | US6096359 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 08/01/2000 | CA2217260C Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/29/2000 | CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil |
| 07/28/2000 | CA2297464A1 Pharmaceutical preparation for the treatment of inflammatory processes |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043404A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases |
| 07/27/2000 | WO2000043401A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043001A1 Anti-inflammatory agents |
| 07/27/2000 | WO2000042852A1 Compounds and methods |
| 07/27/2000 | WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000027832A3 Thiazole derivatives as ppar gamma ligands |
| 07/27/2000 | WO2000023618B1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO2000023068A3 Fumaric acid microtablets |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | CA2361122A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | CA2361064A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | CA2360787A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | CA2358971A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | CA2358474A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/26/2000 | EP1022276A1 Epoxysuccinamide derivatives |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
| 07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021402A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 07/26/2000 | EP1021401A1 Calcitriol derivatives and their uses |
| 07/26/2000 | EP1021200A1 Methods and compositions for treating rheumatoid arthritis |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | EP1021194A1 New improved formulation for treatment of osteoporosis |
| 07/26/2000 | EP1021193A1 THERAPEUTICALLY EFFECTIVE 1$g(a), 25-DIHYDROXYVITAMIN D 3? ANALOGS |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |